HQ Function

The headquarters serves as the primary center for Skyhawk's research and development, drug discovery using its SkySTAR™ platform, clinical operations management, and corporate functions.

Notable Features:

State-of-the-art laboratory facilities optimized for RNA-targeting drug discovery, including advanced molecular biology, chemistry, and bioinformatics capabilities, supporting their cutting-edge research.

Work Culture:

A fast-paced, innovative, and collaborative environment focused on cutting-edge science. Employees are typically mission-driven, aiming to translate novel RNA-targeting research into impactful therapies for patients.

HQ Significance:

The Waltham headquarters is strategically located within one of the world's most prominent biotechnology clusters (Boston/Cambridge area), providing access to top talent, research institutions, and a rich ecosystem of collaborators and service providers. It serves as the nerve center for Skyhawk's pioneering SkySTAR™ platform development.

Values Reflected in HQ: Innovation, scientific rigor, collaboration, and a patient-first mentality are reflected in the HQ's design and operations, fostering an environment conducive to breakthrough discoveries in RNA therapeutics.

Location:

Skyhawk Therapeutics, headquartered in Waltham, MA, USA, extends its reach globally through strategic collaborations with international pharmaceutical companies such as Bristol Myers Squibb, Merck, Takeda, and Genentech. The company conducts clinical trials in multiple countries and maintains a European presence via Skyhawk Therapeutics AG in Basel, Switzerland. This international footprint supports its drug development programs, business development efforts, and aims to address diseases affecting patient populations worldwide.

Street Address:

200 Fifth Avenue, Suite 1300

City:

Waltham

State/Province:

MA

Country:

USA